Most providers willing to consider medical marijuana use in children with cancer, but those with legal eligibility to certify are less likely to approve
Adolescent cannabis use is an independent risk factor for future hypomania—often experienced as part of bipolar disorder—finds new research led by University of Warwick
Collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guideline
Agilent's technology is helping industries advance discovery and development in cannabinoid research and assisting regulators in upholding hemp product safety and quality standards